The clinical phenotype of patients with SMA is most likely multifactorial but generally correlates with SMN2 copy numbers and the amount of the resulting functional SMN protein (SMN-P) [4–6]. This evidence concerns the gene ENSG00000237434 and proximal spinal muscular atrophy.